Skip to main content
. Author manuscript; available in PMC: 2017 Jul 24.
Published in final edited form as: J Immune Based Ther Vaccines Antimicrob. 2013 Jul 1;2(3):29–38. doi: 10.4236/jibtva.2013.23004

Figure 3. Effect of HLA-DR4-derived peptides on IL-17A+, CD3+ double-positive cell differentiation in vitro.

Figure 3

PBMC were incubated with different peptides at different concentrations, with or without TH17-polarizing cytokines. The percentage of IL-17A+, CD3+ double-positive cells was determined by flow cytometry and analyzed statistically as in Figure 2. *, p<0.05; ***, p<0.001 .